- Home
- KRMD vs FSFG Comparison
KRMD vs FSFG Comparison
Compare KRMD & FSFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- FSFG
- Stock Information
- Founded
- KRMD 1980
- FSFG 2008
- Country
- KRMD United States
- FSFG United States
- Employees
- KRMD N/A
- FSFG N/A
- Industry
- KRMD Medical/Dental Instruments
- FSFG Savings Institutions
- Sector
- KRMD Health Care
- FSFG Finance
- Exchange
- KRMD Nasdaq
- FSFG Nasdaq
- Market Cap
- KRMD 182.0M
- FSFG N/A
- IPO Year
- KRMD N/A
- FSFG 2008
- Fundamental
- Price
- KRMD $3.96
- FSFG $24.89
- Analyst Decision
- KRMD Strong Buy
- FSFG Buy
- Analyst Count
- KRMD 4
- FSFG 1
- Target Price
- KRMD $4.13
- FSFG $31.00
- AVG Volume (30 Days)
- KRMD 99.7K
- FSFG 13.4K
- Earning Date
- KRMD 11-13-2024
- FSFG 01-28-2025
- Dividend Yield
- KRMD N/A
- FSFG 2.41%
- EPS Growth
- KRMD N/A
- FSFG 66.39
- EPS
- KRMD N/A
- FSFG 1.98
- Revenue
- KRMD $31,993,796.00
- FSFG $68,091,000.00
- Revenue This Year
- KRMD $17.79
- FSFG N/A
- Revenue Next Year
- KRMD $15.73
- FSFG $2.77
- P/E Ratio
- KRMD N/A
- FSFG $12.57
- Revenue Growth
- KRMD 11.57
- FSFG N/A
- 52 Week Low
- KRMD $1.98
- FSFG $14.55
- 52 Week High
- KRMD $4.60
- FSFG $30.94
- Technical
- Relative Strength Index (RSI)
- KRMD 52.61
- FSFG 35.11
- Support Level
- KRMD $3.79
- FSFG $25.25
- Resistance Level
- KRMD $4.05
- FSFG $27.17
- Average True Range (ATR)
- KRMD 0.18
- FSFG 0.90
- MACD
- KRMD -0.03
- FSFG -0.09
- Stochastic Oscillator
- KRMD 63.92
- FSFG 10.31
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).